Psilocybin therapeutic use program established; protections for registered patients, designated cultivators, registered facilitators, and health care practitioners established; rulemaking authorized; civil actions authorized; fees established; advisory committee established; criminal penalties provided; and money appropriated.

Introduced

In Committee

Floor

Crossed Over

Passed

Enacted

Overview Bill text 2 Compare versions History 6 Sponsors

Apr 22, 2026 · House

Author added Rymer

Mar 16, 2026 · House

Committee report, to adopt as amended and re-refer to Commerce Finance and Policy

Mar 12, 2026 · House

Authors added Repinski and Lee, X.

Feb 25, 2026 · House

Author added West as second author

Apr 1, 2025 · House

Author added Sencer-Mura

Mar 27, 2025 · House

Introduction and first reading, referred to Health Finance and Policy

PASSAGE PROBABILITY

1% Unlikely

Why this number

Stage base Reported from Committee — base rate 11%, measured from MN's completed sessions
Momentum +2 59/100 from the pace of recorded action
Time since last action -22 172 days quiet

A transparent scoring model over stage, momentum, recency, sponsorship and recorded votes — not a trained predictor. Treat it as a way to rank attention, not as a forecast.